Drugs / [ 18F]3F4AP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06999434 | May 2025 → May 2030 expected | Alzheimer disease, multiple sclerosis, radiculopathy, spinal cord injury | Yale University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [ 18F]3F4AP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06999434 ↗ |